Zydus To Continue Mirabegron Sales, Looks To World-First Dual Shigella-Typhoid Vaccine

 
• By Vibha Ravi
  
Zydus Is Counting On Key Products, Launches For FY26 Growth
Zydus Is Counting On Key Products, Launches For FY26 Growth (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Rare Diseases